Accessibility navigation

Potential of stem cells and CART as a potential polytherapy for small cell lung cancer

Skurikhin, E., Pershina, O., Zhukova, M., Widera, D. ORCID:, Ermakova, N., Pan, E., Pakhomova, A. V., Morozov, S., Kubatiev, A. and Dygai, A. (2021) Potential of stem cells and CART as a potential polytherapy for small cell lung cancer. Frontiers in Cell and Developmental Biology, 9. 778020. ISSN 2296-634X

Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.

[img] Text - Accepted Version
· Restricted to Repository staff only


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.3389/fcell.2021.778020


Despite the increasing urgency of the problem of treating small cell lung cancer (SCLC), information on the causes of its development is fragmentary. There is no complete understanding of the features of antitumor immunity and the role of the microenvironment in the development of SCLC resistance. This impedes the development of new methods for the diagnosis and treatment of SCLC. Lung cancer and chronic obstructive pulmonary disease (COPD) have common pathogenetic factors. COPD is a risk factor for lung cancer including SCLC. Therefore, the search for effective approaches to the prevention, diagnosis, and treatment of SCLC in patients with COPD is an urgent task. This review provides information on the etiology and pathogenesis of SCLC, analyses the effectiveness of current treatment options, and critically evaluates the potential of chimeric antigen receptor T cells therapy (CART therapy) in SCLC. Moreover, we discuss potential links between lung cancer and COPD and the role of the endothelium in the development of COPD. Finally, we propose a new approach for increasing the efficacy of CART therapy in SCLC.

Item Type:Article
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
ID Code:101346


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation